eurofeedback for Fibromyalgia.

Not Applicable

• Conditions: Fibromyalgia; Neurological - Other neurological disorders

• Registration Number: ACTRN12623000244606
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-07
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Participants with a diagnosis of fibromyalgia will be eligible to participate.

To be included in the study, participants must meet all of the following inclusion criteria:
•Capable of understanding and signing an informed consent form
•Age between 18 to 75 years on the day of the consent
•Satisfy the Modified American Collage of Rheumatology (ACR) 2011 Fibromyalgia Diagnostic Criteria
•A score greater than or equal to 4 on the 11-point numeric pain rating scale (NPRS, 0=No pain to 10=Worst pain) in the past 7 days
•A disability score of greater than or equal to 50 on Fibromyalgia Impact Questionnaire

Exclusion Criteria

Participants who meet any of the following conditions will be excluded:
•Neurological conditions
•Cognitive and psychiatric disorders
•Epilepsy
•Seizures
•Substance abuse
•Pregnant or six-months post-partum

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Brief pain inventory-short form[Baseline, immediately post-completion of intervention, and at follow-up of 10 days and 1-month post-completion of intervention];Arthritis Impact Questionnaire[Baseline, immediately post-completion of intervention, and at follow-up of 10 days and 1-month post-completion of intervention];Fibromyalgia Impact Questionnaire[Baseline, immediately post-completion of intervention, and at follow-up of 10 days and 1-month post-completion of intervention]